Company Filing History:
Years Active: 2000-2002
Title: Steven Eugene Dunlap: Innovator in Antiviral Compounds
Introduction
Steven Eugene Dunlap is a notable inventor based in Fishers, Indiana. He has made significant contributions to the field of antiviral compounds, holding a total of 2 patents. His work focuses on processes and intermediates that are useful in the development of antifolates and antiviral agents.
Latest Patents
Dunlap's latest patents include innovative processes for creating benzimidazole compounds that inhibit the growth of various picornaviruses. These viruses include rhinoviruses, enteroviruses such as polioviruses, and flaviviruses like hepatitis C virus. The compounds he has developed serve not only as antiviral agents but also as intermediates for preparing additional benzimidazole antiviral compounds.
Career Highlights
Steven Dunlap is currently employed at Eli Lilly and Company, where he continues to advance research in antiviral therapies. His expertise in the field has positioned him as a key contributor to the development of new medicinal compounds.
Collaborations
Dunlap has collaborated with esteemed colleagues, including John Arnold Werner and Louis Nickolaus Jungheim, to further enhance the research and development of antiviral solutions.
Conclusion
Steven Eugene Dunlap's innovative work in the field of antiviral compounds showcases his dedication to advancing medical science. His contributions are vital in the ongoing fight against viral infections, and his patents reflect his commitment to innovation in healthcare.